RheumaGen Funding & Investors
RheumaGen is a gene-editing technology developing therapeutics to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system and stop rheumatoid arthritis's abnormal immune response.
rheumagen.comTotal Amount Raised: $4,906,587
RheumaGen Funding Rounds
Series Unknown
$4,906,587
Funding info provided by Diffbot.